Skip to main content
Premium Trial:

Request an Annual Quote

BioCommerce Week s Index to the Diversified Molecular Biology Tools Companies: Feb 3, 2005

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price (Feb. 1, 2005)
Last Price (Jan. 25, 2005)
% Change
Agilent
A
22.52
21.80
3.30
Applied Biosystems
ABI
20.38
19.88
2.52
BD
BDX
57.60
54.29
6.10
Beckman
BEC
69.01
67.88
1.66
Bio-Rad
BIO
58.88
56.09
4.97
Bruker
BRKR
3.64
3.50
4.00
GE
GE
36.28
35.70
1.62
Harvard Bio
HBIO
4.31
4.23
1.89
Invitrogen
IVGN
68.93
67.43
2.22
Molecular Devices
MDCC
19.20
19.35
-0.78
PerkinElmer
PKI
22.89
21.02
8.90
Sigma
SIAL
63.13
62.31
1.32
Stratagene
STGN
6.67
6.68
-0.15
Thermo
TMO
29.91
29.75
0.54
Waters
WAT
49.71
47.06
5.63
Index Average
35.54
34.46
3.11

BCW Index Rises 3 Percent to Hit New High

PerkinElmer shares gained 9 percent to lead 13 companies whose share prices rose during the five-day period tracked by the BioCommerce Week Index.

The Index, which was launched on Sept. 8, reached a new high with an index price of $35.54 eclipsing the previous high of $35.40 set on Dec. 14.

Becton Dickinson shares gained 6 percent while Waters and Bio-Rad moved up 5 percent. Shares of Molecular Devices and Stratagene were down a fraction as the only companies whose shares fell on the week.

Taken together, the Index outperformed the major indices: The Dow Jones finished the five-day period up a half percent; the S&P 500 and the Nasdaq improved approximately 1.5 percent; while the Amex biotech index was up 2 percent and the Amex pharma index dropped approximately 1.5 percent.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.